Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Coles AJ, Fox E, Vladic A, Gazda SK, Brinar V, Selmaj KW, Skoromets A, Stolyarov I, Bass A, Sullivan H, Margolin DH, Lake SL, Moran S, Palmer J, Smith MS, Compston DA. Coles AJ, et al. Among authors: skoromets a. Neurology. 2012 Apr 3;78(14):1069-78. doi: 10.1212/WNL.0b013e31824e8ee7. Epub 2012 Mar 21. Neurology. 2012. PMID: 22442431 Clinical Trial.
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
CAMMS223 Trial Investigators; Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, Margolin DH, Norris K, Tandon PK. CAMMS223 Trial Investigators, et al. N Engl J Med. 2008 Oct 23;359(17):1786-801. doi: 10.1056/NEJMoa0802670. N Engl J Med. 2008. PMID: 18946064 Free article. Clinical Trial.
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, O'Neill GN; BG-12 Phase IIb Study Investigators. Kappos L, et al. Lancet. 2008 Oct 25;372(9648):1463-72. doi: 10.1016/S0140-6736(08)61619-0. Lancet. 2008. PMID: 18970976 Clinical Trial.
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Diener HC, et al. Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29. Lancet Neurol. 2008. PMID: 18757238 Free PMC article. Clinical Trial.
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group. Gracies JM, et al. Among authors: skoromets a. Lancet Neurol. 2015 Oct;14(10):992-1001. doi: 10.1016/S1474-4422(15)00216-1. Epub 2015 Aug 26. Lancet Neurol. 2015. PMID: 26318836 Clinical Trial.
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation].
Bakhtiiarova KZ, Bragina OV, Vlasov IaV, Greshnova IV, Evdoshenko EP, Ivanishenkova EI, Kairbekova EI, Karnaukhova EN, Korotkevich NA, Leliukhina AV, Protasov IS, Rybina EV, Sazhnev AI, Skoromets AA, Soldatova OA, Trinitatskiĭ IuV, Fedianin AS, Chelnokova SN, Shabanova VD, Sharipova RR, Shchegol'kova EA, Iampol'skaia-Gosteva IA. Bakhtiiarova KZ, et al. Among authors: skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(8):39-45. Zh Nevrol Psikhiatr Im S S Korsakova. 2014. PMID: 25345629 Clinical Trial. Russian.
[Treatment of relapses of multiple sclerosis (a review)].
Brkovich RR, Totolian NA, Sokolov AIu, Ignatov IuD, Skoromets AA. Brkovich RR, et al. Among authors: skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10 Pt 2):69-77. Zh Nevrol Psikhiatr Im S S Korsakova. 2013. PMID: 24416811 Review. Russian.
[Results of a multicenter study of Rebif-22 mcg administration in Russia].
Zavalishin IA, Gusev EI, Iakhno NN, Skoromets AA, Boĭko AN, Demina TL, Burlutskiĭ A P, Beĭn BN, Sholomov II, Pereserdova AV, Stoĭda NI, Zakharova MN, Adarcheva LS, Niiazbekova AS, Askarova LSh, Oleĭnikov VG, Rebrova OIu, Shmidt TE, Davydovskaia MV, Totolian NA, Beskhmel'nitsina IA, Bragina OV, Ponomareva GL, Durseneva OM, Voronchikhina SA, Volkova LI, Turova EL, Streknev AG. Zavalishin IA, et al. Among authors: skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2003;(Spec No 2):73-8. Zh Nevrol Psikhiatr Im S S Korsakova. 2003. PMID: 12938639 Clinical Trial. Russian.
216 results